The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma
- 1 December 2002
- journal article
- Published by Elsevier in British Journal of Plastic Surgery
- Vol. 55 (8) , 623-627
- https://doi.org/10.1054/bjps.2002.3964
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastasesBritish Journal of Cancer, 2001
- c-MYC and nodular malignant melanomaCancer, 2000
- Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanomaBritish Journal of Plastic Surgery, 1999
- Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanomaBritish Journal of Plastic Surgery, 1997
- C-myc gene expression positively correlates with metastatic potential of human melanoma in SCID miceMelanoma Research, 1997
- The clinical significance of oncogene expression in subungual melanomaBritish Journal of Plastic Surgery, 1997
- C-myc oncogene expression in human melanoma and its relationship with tumour antigenicityEuropean Journal of Surgical Oncology, 1996
- The role of c-myc in cell growthCurrent Opinion in Genetics & Development, 1993
- ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutationCell, 1992
- The Role of myc Oncogenes in Cell Growth and DifferentiationAdvances in Dental Research, 1990